Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: A clinical trial

American Journal of Clinical Nutrition

Volumn 91, Issue 4, 2010, Pages 950-957

  Kempf, Kerstin ^a,d   Herder, Christian ^a   Erlund, Iris ^b   Kolb, Hubert ^a,c   Martin, Stephan ^a,d   Carstensen, Maren ^a   Koenig, Wolfgang ^e   Sundvall, Jouko ^b   Bidel, Siamak ^b,f   Kuha, Suvi ^f   Tuomilehto, Jaakko ^b,f,g  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HAGEDORN RESEARCH INSTITUTE   (Denmark)

^d SANA KLINIKUM OFFENBACH   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f UNIVERSITY OF HELSINKI   (Finland)

^g SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; CAFFEIC ACID; CAFFEINE; CHLOROGENIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 18; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLXANTHINE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN; CAFFEIC ACID DERIVATIVE; CHOLESTEROL; DRUG DERIVATIVE; LIPID; PLANT MEDICINAL PRODUCT; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; ASSAY; BEAD BASED MULTIPLEX ASSAY; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COFFEE; CONTROLLED STUDY; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD INTAKE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOASSAY; IMMUNONEPHELOMETRY; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MASS FRAGMENTOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RISK FACTOR; BLOOD; CHEMISTRY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PHASE 3 CLINICAL TRIAL; SINGLE BLIND PROCEDURE;

ADIPONECTIN; ADULT; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEINS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CAFFEIC ACIDS; CAFFEINE; CHLOROGENIC ACID; CHOLESTEROL; COFFEE; DIABETES MELLITUS, TYPE 2; DINOPROST; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-18; LIPIDS; MALE; MIDDLE AGED; PLANT PREPARATIONS; RISK FACTORS; SINGLE-BLIND METHOD;

EID: 77950487925     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28548     Document Type: Article

References (39)

1. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005;294:97-104. (Pubitemid 41002844)
2. Greenberg JA, Boozer CN, Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr 2006;84:682-693
3. Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 2004;291:1213-1219 (Pubitemid 38541664)
4. Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes? Diabetologia 2005;48:1038-1050
5. Kempf K, Rathmann W, Herder C. Impaired glucose regulation and type 2 diabetes in children and adolescents. Diabetes Metab Res Rev 2008;24:427-437
6. Schulze MB, Hoffmann K, Manson JE, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 2005;82:675-684 (Pubitemid 43759255)
7. Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 2006;84:888-893 (Pubitemid 44715672)
8. Williams CJ, Fargnoli JL, Hwang JJ, et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 2008;31:504-507
9. Tunnicliffe JM, Shearer J. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 2008;33:1290-1300
10. Olthof MR, Hollman PC, Katan MB. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 2001;131:66-71.
11. Daglia M, Papetti A, Gregotti C, Berte F, Gazzani G. In vitro antioxidant and ex vivo protective activities of green and roasted coffee. J Agric Food Chem 2000;48:1449-1454
12. Azam S, Hadi N, Khan NU, Hadi SM. Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med Sci Monit 2003;9:BR325-30.
13. Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C. Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 2002;50:6211-6216 (Pubitemid 35155359)
14. Thorand B, Kolb H, Baumert J, et al. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 2005;54:2932-2938
15. Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 2004;80:862-867 (Pubitemid 41202083)
16. Hamer M, Williams ED, Vuononvirta R, Gibson EL, Steptoe A. Association between coffee consumption and markers of inflammation and cardiovascular function during mental stress. J Hypertens 2006;24:2191-2197 (Pubitemid 44611028)
17. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725-731 (Pubitemid 36929335)
18. Oikarinen SI, Erlund I, Mutanen M. Tumour formation in multiple intestinal neoplasia (ApcMin/+) mice fed with filtered or unfiltered coffee. Scand J Food Nutr 2007;51:167-173 (Pubitemid 350249328)
19. Kilkkinen A, Erlund I, Virtanen MJ, Alfthan G, Ariniemi K, Virtamo J. Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers. Am J Epidemiol 2006; 163:687-693
20. Herder C, Schneitler S, Rathmann W, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 2007;92:4569-4574 (Pubitemid 350223428)
21. Herder C, Brunner EJ, Rathmann W, et al. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care 2009;32:421-423
22. Kempf K, Rose B, Herder C, et al. The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. J Mol Med 2007;85:389-396 (Pubitemid 46452255)
23. Stalmach A, Mullen W, Barron D, et al. Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab Dispos 2009;37:1749-1758
24. Ovaskainen ML, Torronen R, Koponen JM, et al. Dietary intake and major food sources of polyphenols in Finnish adults. J Nutr 2008;138:562-566 (Pubitemid 351355258)
25. Kotani K, Tsuzaki K, Sano Y, et al. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med 2008;46:1434-1437
26. Funahashi T, Matsuzawa Y. Hypoadiponectinemia: a common basis for diseases associated with overnutrition. Curr Atheroscler Rep 2006;8:433-438 (Pubitemid 44340189)
27. Dorea JG, da Costa TH. Is coffee a functional food? Br J Nutr 2005;93:773-782
28. Yoshida Y, Hayakawa M, Niki E. Evaluation of the antioxidant effects of coffee and its components using the biomarkers hydroxyoctadecadienoic acid and isoprostane. J Oleo Sci 2008;57:691-697
29. Natella F, Nardini M, Belelli F, Scaccini C. Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. Am J Clin Nutr 2007;86:604-609 (Pubitemid 47435826)
30. Esposito F, Morisco F, Verde V, et al. Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. Aliment Pharmacol Ther 2003;17:595-601. (Pubitemid 36384819)
31. Mursu J, Voutilainen S, Nurmi T, et al. The effects of coffee consumption on lipid peroxidation and plasma total homocysteine concentrations: a clinical trial. Free Radic Biol Med 2005;38:527-534 (Pubitemid 40253516)
32. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009;202:321-329
33. Aro A, Tuomilehto J, Kostiainen E, Uusitalo U, Pietinen P. Boiled coffee increases serum low density lipoprotein concentration. Metabolism 1987;36:1027-1030 (Pubitemid 18025028)
34. Jee SH, He J, Appel LJ, et al. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2001;153:353-362 (Pubitemid 32144561)
35. Carson CA, Cauley JA, Caggiula AW. Relation of caffeine intake to blood lipids in elderly women. Am J Epidemiol 1993;138:94-100.
36. Fried RE, Levine DM, Kwiterovich PO, et al. The effect of filtered-coffee consumption on plasma lipid levels. Results of a randomized clinical trial. JAMA 1992;267:811-815
37. Hivert MF, Sun Q, Shrader P, Mantzoros CS, Meigs JB, Hu FB. Circulating IL-18 and the risk of type 2 diabetes in women. Diabetologia 2009;52:2101-2108
38. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-58 (Pubitemid 34756495)
39. Spranger J, Kroke A, Möhlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226-228 (Pubitemid 36126226)